MoneyWorks4Me

Bacil Pharma - Quaterly Results

14 Aug 2024 Evaluate
A slight decline in the revenue of Rs. 0.00 millions was seen for the June 2024 quarter as against Rs. 0.00 millions during year-ago period.The Net Loss for the quarter ended June 2024 is Rs. -0.33 millions as compared to Net Profit of Rs. 0.17 millions of corresponding quarter ended June 2023Operating profit Margin for the quarter ended June 2024 slipped to -0.33% as compared to 0.18% of corresponding quarter ended June 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 0.11 0.48 -77.08 0.11 0.48 -77.08 1.31 1.15 13.91
PBIDT -0.33 0.18 -283.33 -0.33 0.18 -283.33 -0.57 -0.99 -42.42
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -0.33 0.18 -283.33 -0.33 0.18 -283.33 -0.57 -0.99 -42.42
Depreciation 0.00 0.01 0.00 0.00 0.01 0.00 0.02 0.03 -33.33
PBT -0.33 0.17 -294.12 -0.33 0.17 -294.12 -0.59 -1.02 -42.16
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -0.33 0.17 -294.12 -0.33 0.17 -294.12 -0.59 -1.02 -42.16
Equity 58.90 58.90 0.00 58.90 58.90 0.00 58.90 58.90 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..